Prof. Brian BADGWELL MD Andersen Cancer Center USA

Biosketch

Dr Badgwell has a cancer-directed practice in gastric and gastroesophageal cancer at MD Anderson that incorporates recent progress in advanced laparoscopic surgery and intraperitoneal chemotherapy. Dr Badgwell was the Principal Investigator for the first three completed clinical trials of hyperthermic intraperitoneal chemotherapy (HIPEC) for metastatic gastric cancer in the United States, and is currently the Principal Investigator for ongoing trials of intraperitoneal paclitaxel and short course neoadjuvant chemoradiotherapy. Dr Badgwell has established a palliative surgery research program dedicated to improving the quality of life for patients with symptoms due to advanced cancer and, with funding through the American Cancer Society, has developed the first validated symptom assessment questionnaire for patients with malignant bowel obstruction.